NEMATODIASIS

This adverse event was reported 34 times

NEMATODIASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IVERMECTIN 9 0.0020
1 DIFLUPREDNATE OPHTHALMIC 1 0.0011
2 ALBENDAZOLE 1 0.0005
3 DIFLUPREDNATE 1 0.0003
4 MEPOLIZUMAB 12 0.0002
5 CEFOTAXIME INJECTION 1 0.0002
6 ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE 1 0.0001
7 TENOFOVIR DISOPROXIL FUMARATE TABLETS 1 0.0001
8 DOXYCYCLINE HYCLATE 7 0.0001
9 DOXYCYCLINE 7 0.0001
See all drugs enriched for association with NEMATODIASIS

NEMATODIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 12 0.0174
1 Antiparasitic [EPC] 9 0.0020
2 Pediculicide [EPC] 9 0.0019
3 Anthelmintic [EPC] 1 0.0003
4 Tetracycline-class Drug [EPC] 7 0.0001
5 Anticholinergic [EPC] 1 0.0001
6 Antimetabolite Immunosuppressant [EPC] 1 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
9 Protease Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with NEMATODIASIS